HBC — Hofseth Biocare ASA Share News
0.000.00%
Last trade - 00:00- NOK513.85m
- NOK746.89m
- NOK256.34m
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering
Brief: Hofseth Biocare Announces Partnership With Metabolic Elite
Brief: Hofseth Biocare Q3 Revenue NOK 54.9 Million
Brief: Hofseth Biocare Says Private Placement Successfully Placed
Brief: Hofseth Biocare: Aecorbio Secures Further $1.5 Mln At $30 Mln Valuation
Brief: Hofseth Biocare Q2 Revenue NOK 68.4 Million
Brief: Hofseth Biocare Q1 Revenue NOK 60.9 Million
Brief: Hofseth Biocare Places CHF-Denominated Unsecured Bonds
Brief: Hofseth Biocare Considers Unsecured Bond Issuance
Brief: Hofseth Biocare Signs Strategic Partnership With Symrise
Brief: Hofseth Biocare Q4 Adjusted EBITDA Loss NOK 26.1 Mln
Brief: Hofseth Biocare Q3 Revenue NOK 67.9 Million
Brief: Hofseth Biocare CFO Christel Elise Kanli Resigs
Brief: Hofseth Biocare Q2 Gross Oper Rev Up At NOK 80.4 Mln
Brief: Hofseth Biocare Transfers Eosinophil-Targeting Drug Candidate To Subsidiary
Brief: Reg-Hofseth Biocare Agrees China Distribution Partnership With Shanghai-Based Lithy